Literature DB >> 24070383

Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.

Marie-Luise Berres1, Carl E Allen, Miriam Merad.   

Abstract

Histiocytic disorders represent a group of complex pathologies characterized by the accumulation of histiocytes, an old term for tissue-resident macrophages and dendritic cells. Langerhans cell histiocytosis is the most frequent of histiocytosis in humans and has been thought to arise from the abnormal accumulation of epidermal dendritic cells called Langerhans cells. In this chapter, we discuss the origin and differentiation of Langerhans cells and dendritic cells and present accumulated evidence that suggests that Langerhans cell histiocytosis does not result from abnormal Langerhans cell homeostasis but rather is a consequence of misguided differentiation programs of myeloid dendritic cell precursors. We propose reclassification of Langerhans cell histiocytosis, juvenile xanthogranuloma, and Erdheim-Chester disease as inflammatory myeloid neoplasias.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRAFV600E; DC differentiation; Dendritic cell lineage; Erdheim–Chester disease; Histiocytic disorders; Juvenile xanthogranuloma; Langerhans cell histiocytosis; Macrophages

Mesh:

Year:  2013        PMID: 24070383      PMCID: PMC3985340          DOI: 10.1016/B978-0-12-417028-5.00005-3

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  180 in total

1.  Identification of lineage relationships and novel markers of blood and skin human dendritic cells.

Authors:  Andrew N Harman; Chris R Bye; Najla Nasr; Kerrie J Sandgren; Min Kim; Sarah K Mercier; Rachel A Botting; Sharon R Lewin; Anthony L Cunningham; Paul U Cameron
Journal:  J Immunol       Date:  2012-11-26       Impact factor: 5.422

2.  CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis.

Authors:  Samira Tamoutounour; Sandrine Henri; Hugues Lelouard; Béatrice de Bovis; Colin de Haar; C Janneke van der Woude; Andrea M Woltman; Yasmin Reyal; Dominique Bonnet; Dorine Sichien; Calum C Bain; Allan McI Mowat; Caetano Reis e Sousa; Lionel F Poulin; Bernard Malissen; Martin Guilliams
Journal:  Eur J Immunol       Date:  2012-10-17       Impact factor: 5.532

3.  Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.

Authors:  Rina Kansal; Leticia Quintanilla-Martinez; Vivekananda Datta; Jean Lopategui; Gary Garshfield; Bharat N Nathwani
Journal:  Genes Chromosomes Cancer       Date:  2012-09-21       Impact factor: 5.006

4.  Specialized role of migratory dendritic cells in peripheral tolerance induction.

Authors:  Juliana Idoyaga; Christopher Fiorese; Lori Zbytnuik; Ashira Lubkin; Jennifer Miller; Bernard Malissen; Daniel Mucida; Miriam Merad; Ralph M Steinman
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 5.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

6.  Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Jean-François Emile; Laurent Arnaud; Philippe Maksud; Frédéric Charlotte; Philippe Cluzel; Aurélie Drier; Baptiste Hervier; Neïla Benameur; Sophie Besnard; Jean Donadieu; Zahir Amoura
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

7.  The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.

Authors:  Silvy da Rocha Dias; Tomas Salmonson; Barbara van Zwieten-Boot; Bertil Jonsson; Serena Marchetti; Jan H M Schellens; Rosa Giuliani; Francesco Pignatti
Journal:  Eur J Cancer       Date:  2013-03-05       Impact factor: 9.162

8.  Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.

Authors:  Chun I Yu; Christian Becker; Yuanyuan Wang; Florentina Marches; Julie Helft; Marylene Leboeuf; Esperanza Anguiano; Stephane Pourpe; Kristina Goller; Virginia Pascual; Jacques Banchereau; Miriam Merad; Karolina Palucka
Journal:  Immunity       Date:  2013-04-04       Impact factor: 31.745

9.  Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia.

Authors:  Melanie Greter; Iva Lelios; Miriam Merad; Burkhard Becher; Pawel Pelczar; Guillaume Hoeffel; Jeremy Price; Marylene Leboeuf; Thomas M Kündig; Karl Frei; Florent Ginhoux
Journal:  Immunity       Date:  2012-11-21       Impact factor: 31.745

10.  Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells.

Authors:  V Cerovic; S A Houston; C L Scott; A Aumeunier; U Yrlid; A M Mowat; S W F Milling
Journal:  Mucosal Immunol       Date:  2012-06-20       Impact factor: 7.313

View more
  26 in total

1.  Langerhans cell histiocytosis presenting as Crohn's disease: a case report.

Authors:  Amelie Therrien; Zaki El Haffaf; Claire Wartelle-Bladou; Justin Côté-Daigneault; Bich N Nguyen
Journal:  Int J Colorectal Dis       Date:  2018-05-08       Impact factor: 2.571

2.  Differentiating skin-limited and multisystem Langerhans cell histiocytosis.

Authors:  Stephen J Simko; Benjamin Garmezy; Harshal Abhyankar; Philip J Lupo; Rikhia Chakraborty; Karen Phaik Har Lim; Albert Shih; M John Hicks; Teresa S Wright; Moise L Levy; Kenneth L McClain; Carl E Allen
Journal:  J Pediatr       Date:  2014-10-21       Impact factor: 4.406

Review 3.  Pediatric lymphomas and histiocytic disorders of childhood.

Authors:  Carl E Allen; Kara M Kelly; Catherine M Bollard
Journal:  Pediatr Clin North Am       Date:  2015-02       Impact factor: 3.278

4.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

5.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

6.  Hydroxyurea: a new old therapy for Langerhans cell histiocytosis.

Authors:  Daniel J Zinn; Amanda B Grimes; Howard Lin; Olive Eckstein; Carl E Allen; Kenneth L McClain
Journal:  Blood       Date:  2016-09-29       Impact factor: 22.113

7.  Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

Authors:  Rikhia Chakraborty; Thomas M Burke; Oliver A Hampton; Daniel J Zinn; Karen Phaik Har Lim; Harshal Abhyankar; Brooks Scull; Vijetha Kumar; Nipun Kakkar; David A Wheeler; Angshumoy Roy; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; D Williams Parsons; Carl E Allen
Journal:  Blood       Date:  2016-10-11       Impact factor: 22.113

8.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

9.  Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.

Authors:  James Laird; Jennifer Ma; Karen Chau; Monica Chelius; Weiji Shi; Zhigang Zhang; Benjamin H Lok; Joachim Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-06       Impact factor: 7.038

10.  Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.

Authors:  Florian Halbritter; Matthias Farlik; Raphaela Schwentner; Gunhild Jug; Nikolaus Fortelny; Thomas Schnöller; Hanja Pisa; Linda C Schuster; Andrea Reinprecht; Thomas Czech; Johannes Gojo; Wolfgang Holter; Milen Minkov; Wolfgang M Bauer; Ingrid Simonitsch-Klupp; Christoph Bock; Caroline Hutter
Journal:  Cancer Discov       Date:  2019-07-25       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.